Andrea Tan
Stock Analyst at Goldman Sachs
(1.65)
# 3,320
Out of 5,072 analysts
49
Total ratings
44.74%
Success rate
-6.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Neutral | $27 → $48 | $57.71 | -16.83% | 2 | Nov 20, 2025 | |
| INSM Insmed | Maintains: Buy | $196 → $225 | $204.51 | +10.02% | 13 | Oct 31, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.44 | +227.87% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $80.50 | -36.65% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $9.41 | +186.93% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $7.08 | -15.25% | 5 | Jul 1, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $4.19 | -52.27% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $22.44 | -91.09% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $218.95 | -26.92% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $3.64 | +559.34% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.10 | +263.64% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $601.03 | -37.61% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $7.95 | +906.29% | 2 | May 24, 2022 |
Arrowhead Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $27 → $48
Current: $57.71
Upside: -16.83%
Insmed
Oct 31, 2025
Maintains: Buy
Price Target: $196 → $225
Current: $204.51
Upside: +10.02%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.44
Upside: +227.87%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $80.50
Upside: -36.65%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $9.41
Upside: +186.93%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $7.08
Upside: -15.25%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $4.19
Upside: -52.27%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $22.44
Upside: -91.09%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $218.95
Upside: -26.92%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $3.64
Upside: +559.34%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.10
Upside: +263.64%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $601.03
Upside: -37.61%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $7.95
Upside: +906.29%